Nasdaq: India's Alembic Pharma posts near-seven-fold jump in Q4 profit on strong sales
India's Alembic Pharma posts near-seven-fold jump in Q4 profit on strong sales
BENGALURU, Feb 1 (Reuters) - Indian generic drugmaker Alembic Pharmaceuticals Ltd ALEM.NS on Wednesday reported third-quarter profit that beat analyst expectations, helped by strong sales in its ...
Alembic Pharmaceuticals on Friday said it has commenced sales of an oral penicillin-class antibiotic in the US market. The company has commenced sales of Pivya (pivmecillinam) tablets following its ...
Nasdaq: India's Alembic Pharma beats Q3 profit view on strong domestic, US sales
BENGALURU, Feb 5 (Reuters) - India's Alembic Pharmaceuticals ALEM.NS reported a bigger-than-expected third-quarter profit on Monday, driven by higher sales in the domestic and U.S. markets. The ...
India's Alembic Pharma beats Q3 profit view on strong domestic, US sales
Reuters: India's Alembic Pharmaceuticals first-quarter profit jumps on strong US, domestic sales
Aug 5 (Reuters) - India's Alembic Pharmaceuticals (ALEM.NS), opens new tab reported a 14.6% rise in consolidated profit for the first quarter on Tuesday, driven by strong sales in the U.S. and India.
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Alembic, a startup developing sales software that correlates customer ...
moneycontrol.com: Alembic Pharma Consolidated September 2025 Net Sales at Rs 1,910.15 crore, up 15.91% Y-o-Y
Alembic Pharma Consolidated September 2025 Net Sales at Rs 1,910.15 crore, up 15.91% Y-o-Y
moneycontrol.com: Alembic Pharma Consolidated December 2025 Net Sales at Rs 1,876.31 crore, up 10.84% Y-o-Y